Exact Mass: 317.1852

Exact Mass Matches: 317.1852

Found 70 metabolites which its exact mass value is equals to given mass value 317.1852, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Suberoyl-L-carnitine

4-[(7-Carboxyheptanoyl)oxy]-4-(trimethylammonio)butanoic acid

C15H27NO6 (317.1838)


Suberoyl-L-carnitine is an acylcarnitine. More specifically, it is an suberoic aicd ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Suberoyl-L-carnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine Suberoyl-L-carnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

3-methylheptanedioylcarnitine

3-[(6-carboxy-3-methylhexanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C15H27NO6 (317.1838)


3-methylheptanedioylcarnitine is an acylcarnitine. More specifically, it is an 3-methylheptanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-methylheptanedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 3-methylheptanedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

2,4-dimethylhexanedioylcarnitine

3-[(5-carboxy-3,5-dimethylpentanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C15H27NO6 (317.1838)


2,4-dimethylhexanedioylcarnitine is an acylcarnitine. More specifically, it is an 2,4-dimethylhexanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 2,4-dimethylhexanedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 2,4-dimethylhexanedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Octanedioylcarnitine

3-[(7-carboxyheptanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C15H27NO6 (317.1838)


Octanedioylcarnitine is an acylcarnitine. More specifically, it is an octanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. octanedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine octanedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. In particular octanedioylcarnitine is elevated in the blood or plasma of individuals with pulmonary arterial hypertension (PMID: 32108049) and type 2 diabetes mellitus (PMID: 19369366). Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Tetradecyl sodium sulfate

Tetradecyl sodium sulfate

C14H30NaO4S+ (317.1762)


   

C1=CC=C2C3=CC=C4OC(CCC=C(C)C)(C)C=CC4=C3NC2=C1

C1=CC=C2C3=CC=C4OC(CCC=C(C)C)(C)C=CC4=C3NC2=C1

C22H23NO (317.178)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

4-(Morpholine-4-carbonyl)phenylboronic Acid Pinacol Ester

4-(Morpholine-4-carbonyl)phenylboronic Acid Pinacol Ester

C17H24BNO4 (317.1798)


   

BENZYL-[2-(4-BENZYLOXY-PHENYL)-ETHYL]-AMINE

BENZYL-[2-(4-BENZYLOXY-PHENYL)-ETHYL]-AMINE

C22H23NO (317.178)


   

(4-BENZYLOXYBENZYL)-(1-PHENYL-ETHYL)AMINE

(4-BENZYLOXYBENZYL)-(1-PHENYL-ETHYL)AMINE

C22H23NO (317.178)


   

MORPHOLINO(3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)METHANONE

MORPHOLINO(3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)METHANONE

C17H24BNO4 (317.1798)


   

4-CYANO-3-FLUOROPHENYL TRANS-4-PENTYLCYCLOHEXANECARBOXYLATE

4-CYANO-3-FLUOROPHENYL TRANS-4-PENTYLCYCLOHEXANECARBOXYLATE

C19H24FNO2 (317.1791)


   

N-(2-Methoxyphenyl)-2-(di-t-butylphosphino)pyrrole

N-(2-Methoxyphenyl)-2-(di-t-butylphosphino)pyrrole

C19H28NOP (317.1908)


   

Sodium hydroxytetradecane sulfonate

Sodium hydroxytetradecane sulfonate

C14H30NaO4S (317.1762)


   
   

2-[(4-phenylpiperidin-1-yl)methyl]quinolin-6-amine

2-[(4-phenylpiperidin-1-yl)methyl]quinolin-6-amine

C21H23N3 (317.1892)


   

(L)-Suberyl Carnitine

(3R)-3-[(7-Carboxyheptanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C15H27NO6 (317.1838)


   

Terodiline hydrochloride

Terodiline hydrochloride

C20H28ClN (317.191)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics C78281 - Agent Affecting Musculoskeletal System > C29696 - Muscle Relaxant C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators

   

Alverine hydrochloride

Alverine hydrochloride

C20H28ClN (317.191)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent

   

(E)-2-Benzylidene-3-(cyclohexylamino)-2,3-dihydro-1H-inden-1-one

(E)-2-Benzylidene-3-(cyclohexylamino)-2,3-dihydro-1H-inden-1-one

C22H23NO (317.178)


   

L-Seryl-L-leucyl-L-valine

L-Seryl-L-leucyl-L-valine

C14H27N3O5 (317.1951)


   

1-Tert-butyl-5-[2-oxo-2-(1-piperidinyl)ethyl]-4-pyrazolo[3,4-d]pyrimidinone

1-Tert-butyl-5-[2-oxo-2-(1-piperidinyl)ethyl]-4-pyrazolo[3,4-d]pyrimidinone

C16H23N5O2 (317.1852)


   

(2S,3S,7R)-2,3-diamino-8-(1-carbamoyl-2-iminoimidazolidin-4-yl)-7-hydroxyoctanoate

(2S,3S,7R)-2,3-diamino-8-(1-carbamoyl-2-iminoimidazolidin-4-yl)-7-hydroxyoctanoate

C12H25N6O4+ (317.1937)


   

3-methylheptanedioylcarnitine

3-methylheptanedioylcarnitine

C15H27NO6 (317.1838)


   

2,4-dimethylhexanedioylcarnitine

2,4-dimethylhexanedioylcarnitine

C15H27NO6 (317.1838)


   

Leu-Val-Ser

Leu-Val-Ser

C14H27N3O5 (317.1951)


A tripeptide composed of L-leucine, L-valine and L-serine joined in sequence by peptide linkages.

   

1-(2-Phenylethyl)-3-[(4-propylcyclohexylidene)amino]thiourea

1-(2-Phenylethyl)-3-[(4-propylcyclohexylidene)amino]thiourea

C18H27N3S (317.1926)


   

2-phenyl-N-(2-(pyrrolidin-1-yl)ethyl)quinolin-4-amine

2-phenyl-N-(2-(pyrrolidin-1-yl)ethyl)quinolin-4-amine

C21H23N3 (317.1892)


   
   

N-[2-(1-cyclohexenyl)ethyl]-3-[(4-methylphenyl)methylthio]propanamide

N-[2-(1-cyclohexenyl)ethyl]-3-[(4-methylphenyl)methylthio]propanamide

C19H27NOS (317.1813)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

O-suberoylcarnitine

O-suberoylcarnitine

C15H27NO6 (317.1838)


An O-acylcarnitine having suberoyl (7-carboxyheptanoyl) as the acyl substituent.

   

(3R)-3-[(7-Carboxyheptanoyl)oxy]-4-(trimethylazaniumyl)butanoate

(3R)-3-[(7-Carboxyheptanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C15H27NO6 (317.1838)


   
   
   

13,16-dimethyl-18-(prop-1-en-2-yl)-15-oxa-4-azapentacyclo[14.2.1.0²,¹⁴.0³,¹¹.0⁵,¹⁰]nonadeca-2(14),3(11),5(10),6,8,12-hexaene

13,16-dimethyl-18-(prop-1-en-2-yl)-15-oxa-4-azapentacyclo[14.2.1.0²,¹⁴.0³,¹¹.0⁵,¹⁰]nonadeca-2(14),3(11),5(10),6,8,12-hexaene

C22H23NO (317.178)


   

3,10-dimethyl-3-(3-methylbut-2-en-1-yl)-6h-pyrano[2,3-c]carbazole

3,10-dimethyl-3-(3-methylbut-2-en-1-yl)-6h-pyrano[2,3-c]carbazole

C22H23NO (317.178)


   

(2s)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxy-3-methylbutylidene]amino}-3-hydroxypropanoic acid

(2s)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxy-3-methylbutylidene]amino}-3-hydroxypropanoic acid

C14H27N3O5 (317.1951)